2021 agenda

Friday October 29, 2021

10:00- 10:05 Welcome to CMHCC Dr. Brandon Meyers
10:05- 11:40 Early Stage Disease Chair: Dr. Gonzalo Sapisochin
10:10 – 10:25 Non Surgical Techniques for Curative Intent of Small Burden Disease Dr. David Liu
10:25 – 10:35 The Role of External Beam Radiation Therapy in the Treatment of Early Stage HCC Dr. Laura Dawson
10:35 – 10:50 The ABCs of Transplant Selection: When is it Time to Say No? Dr. Gonzalo Sapisochin
10:50 – 11:05 Pushing the Envelope in Surgical Resection for Patients with Early Stage HCC. Dr. Giammauro Berardi
11:05- 11:20 Question and Answer Period
11:20 – 11:40 Early Stage Disease Panel Discussion/Cases with Audience Chair: Dr. Sapisochin, Panel: Drs. Dawson, Berardi, Liu,
11:40 – 12:30 Lunch Break
12:30 – 12:35 Afternoon Intro Dr. Vincent Tam
12:35 – 13:55 Intermediate Stage Disease Chair: Dr. Laura Dawson
12:35 – 12:50 BCLC Staging System – The Strengths, Limitations and How it Can Be Improved Dr. Rob Beecroft
12:50 – 13:05 Definition of TACE Refractory and What Do We Do Next (TARE, SBRT or Systemic Therapy) Dr. Kelly Burak
13:05 – 13:20 Systemic Therapy in Intermediate Stage HCC Dr. Howard Lim
13:20 – 13:35 Question and Answer Period
13:35- 13:55 Intermediate Stage Disease Panel Discussion/Cases with Audience Chair: Dr. Dawson, Panel: Drs. Beecroft, Burak, Hosni, Lim, Meyers
13:55 – 14:10 Refreshment Break
14:10 – 14:30 Keynote: Role of Current and Future Biomarkers in the Management of HCC Dr. Richard Finn
14:30 – 14:40 Question and Answer Period
14:40 – 15:55 Advanced Stage Disease Chair: Dr. Jennifer Knox
14:45 – 15:00 Current Systemic Treatment of HCC Dr. Vincent Tam
15:00 – 15:15 Future Systemic Therapy Options in HCC. Dr. Rachel Goodwin
15:15 – 15:25 Question and Answer Period
15:25 – 15:55 Panel Discussion/Cases with Audience Chair: Dr. Knox, Panel: Drs. Dawson, Goodwin,  Ramjeesingh, Tam
15:55 – 16:00 Closing Remarks Dr. Brandon Meyers